Skip to main content

MANGALAM · Mangalam Drugs And Organics Limited · Financials

29.03 INR -0.07 (-0.24%) At close · Nov 13
Volume · Nov 13 406 Avg daily vol (14 sessions) 1804

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
2.32B -27.1%
FY2026 Revenue FY2024–FY2026
Net Income
0
FY2026 Net Income FY2024–FY2026
Operating Cash Flow
41.78M -90.2%
FY2026 Operating Cash Flow FY2024–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024
INR 2.62B 2.32B 3.18B 3.69B
INR 173.23M 182.23M 166.07M 146.51M
INR 146.98M 162.08M 149.33M 139.17M
INR -388.43M -485.71M 47.86M -110.73M
INR -7.41M -41.71M -19.35M -20.02M
INR -98.36M 0 0 0
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.